Green leaf pharmaceutical Siruikang, reached the Korean market distribution cooperation!
-
Last Update: 2020-06-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Yesterday, Green leaf pharmaceuticals announced that its wholly-owned subsidiary, Luye Hong Kong Limited, and Alvogen Korea Co., Ltd("Alvogen") have signed exclusive distribution and promotion agreements in South Korea for the ® of Silikeon ® and Sirecon Relief FilmsThe announcement showed that the Silikon ® ( Fumaquinsulpin, Quick Release, IR) and the Serikang Slow Release ® (Slow Release Preparations) were atypical antipsychotic drugs with antidepressant propertiesThe main conditions of sie-kang ® are the treatment of schizophrenia and bipolar disorderThe Siekang Probation ® has also been approved for use in a number of markets for depression and generalised anxiety disordersAccording to IQVIA, Sirekang ® sales in South Korea reached 12.9 billion won in 2019The Korean Central Nervous (CNS) pharmaceutical market grew at a COMPOUND annual growth rate (CAGR) of 7.0% in 2017-2019
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
